Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-16 · accession 0001415889-23-012360 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-17 | 2023-08-16 | OLMA | Harmon Cyrus | Dir | S - Sale | $10.14 | -15.0K | 1.02M | -1% | -$152.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-16 | S | D | 15,000 | $10.14 | 1,023,714 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person dated May 16, 2023. |